NTRA Stock Chart & Fundamental Analysis

Fundamentals Charts

About NATERA INC

Name

NATERA INC

CEO

Steven Leonard Chapman

Website

www.natera.com

Industry

Healthcare

Year Founded

2003

Employees

6,138

Natera, Inc. (NASDAQ: NTRA) develops genetic testing and molecular monitoring products for healthcare, operating in diagnostics and research, with $2.3 billion in revenue in FY2025. Its menu spans reproductive health, oncology, and transplant testing, pairing laboratory-developed assays with direct sales and partner distribution on a global basis.

Analyst Ratings

Consensus Recommendation

Buy5

Hold0

Sell2

Fundamentals & Financials

Revenue (TTM)

$2.7B

Net Income (TTM)

-$192.3M

EPS (TTM)

-$1.36

ROA (TTM)

-7.24%

Current Ratio

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$752,750K	$696,644K	$665,500K
Cost of Sales	$267,561K	$245,203K	$218,682K
Gross Profit	$485,189K	$451,441K	$446,818K
Operating Income	-$75,792K	-$93,516K	-$22,786K
Net Income	-$66,969K	-$85,091K	$47,258K
EPS	-$0.47	-$0.6	$0.35

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

NATERA INC's Technical Indicators Summary

NTRA is rated Buy at 318.35, supported by strong price positioning and upward momentum. The stock trades well above its key moving averages, including the 200-day level in the low two hundreds, and OBV confirms accumulation, which together signal durable breadth. Momentum signals are mixed with an overbought RSI but very strong CCI and a positive MACD that underscore upward pressure, while ADX in the mid-20s suggests a developing trend. Bollinger bands show the price extended and ATR indicates moderate volatility. Technical takeaway: Buy — price strength and volume favor bulls despite short-term overbought readings.

Buy

5 signals

Neutral

0 signals

Sell

2 signals

Overall: Bullish71% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	72.10	Sell	RSI (72.10) > 70, indicating overbought conditions.
Stochastic %K (14, 3, 3)	81.09	Sell	Stochastic (81.09) > 80, indicating overbought.
CCI (20)	295.25	Buy	CCI (295.25) > 100, indicating strong upward momentum.
WPR (14)	-9.85	Sell	Williams %R (-9.85) > -20, indicating overbought.
Momentum (10)	60.32	Buy	Momentum (60.32) is positive.
MFI	68.98	Neutral	MFI (68.98) is neutral.
MACD Level (12, 26)	10.99	Buy	Confirmed uptrend: MACD (10.99) is positive and above its signal line (6.69).
Bollinger Bands	$236.37 - $307.58	Sell	Price ($318.35) is above the upper band ($307.58).
ATR (14)	$14.68 (4.61%)	Neutral	Moderate Volatility (4.61%).
ADX (14)	24.43	Neutral	Weak or consolidating trend (ADX < 25). ADX(24.43), +DI(39.61), -DI(12.51)
OBV	46,375,141	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(46,375,141), 20D-SMA-OBV(46,093,900)
Classic Pivot Point	$317.16	Neutral	Price ($318.35) is above the pivot ($317.16) but not yet breaking resistance R1 ($327.95) — mildly bullish / neutral zone.
Fibonacci Pivot Point	$317.16	Neutral	Price ($318.35) is above the pivot ($317.16) but not yet breaking resistance R1 ($323.52) — mildly bullish / neutral zone.
Simple Moving Averages	$223.75 - $276.95(5 indicators)	Buy	SMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$224.07 - $284.99(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A gentle pullback defined the last session for NTRA, which slipped -1.16% by the close. NTRA may move on a notable insider transaction, per Motley Fool, as shares hover near record highs.

Trading Volume

Above 10d avg 1.6M

2.1M

vs S&P 500 Today

Underperforming Market

-1.10%

52-Week Position

Near highs

95.6%

Updated: August 11, 2026 at 12:52 UTC